<!-- received="Fri Sep 27 19:37:49 1996 MST" -->
<!-- sent="Fri, 27 Sep 1996 18:28:47 PST" -->
<!-- name="Michael Butler" -->
<!-- email="mbutler@ocv1.ocv.com" -->
<!-- subject="Deprenyl (was Re: DHEA)" -->
<!-- id="UPMAIL02.199609280116470368@msn.com" -->
<!-- inreplyto="DHEA)" -->
<title>extropians: Deprenyl (was Re: DHEA)</title>
<h1>Deprenyl (was Re: DHEA)</h1>
Michael Butler (<i>mbutler@ocv1.ocv.com</i>)<br>
<i>Fri, 27 Sep 1996 18:28:47 PST</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#1351">[ date ]</a><a href="index.html#1351">[ thread ]</a><a href="subject.html#1351">[ subject ]</a><a href="author.html#1351">[ author ]</a>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="1352.html">Sarah Marr: "(&gt;H) Virtual Reality &amp; People"</a>
<li> <b>Previous message:</b> <a href="1350.html">David Musick: "Holistic Unity and Red Boxes"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
</ul>
<hr>
<!-- body="start" -->
<i>&gt;Surely a liquid sublingual variety should </i><br>
available sometime soon, if not now.<br>
<p>
This brings up a quasi-related question, one that may be better taken <br>
elsewhere, but I'll ask: what're the legal options these days for <br>
getting ahold of Deprenyl?<br>
<p>
MMB, at but not for OCV<br>
<!-- body="end" -->
<hr>
<p>
<ul>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="1352.html">Sarah Marr: "(&gt;H) Virtual Reality &amp; People"</a>
<li> <b>Previous message:</b> <a href="1350.html">David Musick: "Holistic Unity and Red Boxes"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
</ul>
